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The multiple logistic risk model was used to assess the comparative strength of systolic, diastolic, mean arterial and pulse pressure for the prediction of CHD in two age decades after adjust-IT IS ESTIMATED that hypertension occurs in some 25,000,000 Americans, of whom only one-half are aware of it and only one-eighth are adequately controlled.' These statistics are alarming since hypertension has been identified as perhaps the most universal contributor to all forms of cardiovascular disease2 and one of the strongest predictive risk factors for coronary heart disease (CHD).3 6 Although both systolic and diastolic blood pressure are recognized predictors of CHD risk,7' 8 most physicians are accustomed to considering the diastolic blood pressure as the contributor to vascular pathology. On the other hand, this viewpoint has been questioned" and a number of studies have found that the systolic is a better predictor of CHD than is the diastolic ment for age, serum cholesterol, cigarette smoking, behavior pattern and weight. The risk of CHD was more strongly associated with the systolic than the diastolic pressure. The general practice of assessing the importance of blood pressure based only on the diastolic component should be reassessed.
ing."5 16 This issue has obvious therapeutic implications in view of the general clinical practice of assessing the impact of blood pressure primarily on the basis of the diastolic component. The present analysis was conducted to help settle this important controversy.
Methods and Materials
The Western Collaborative Group Study (WCGS) is a prospective epidemiological study of 3,154 initially well men, aged 39 to 59 years at intake in 1960-61 and employed in ten California companies.'7 Data collection was terminated with the annual re-examination in 1969, resulting in 8.5 years of follow-up. Detailed descriptions of the study population and methodology are provided in earlier reports,'7 20 and only those features which are particularly relevant to the present report are again described.
The risk factors studied in the present analysis are systolic and diastolic blood pressures, serum cholesterol, cigarette smoking, age and behavior pattern since these variables were found by multivariate analysis to be significantly associated with the incidence of CHD in the WCGS population. One analysis also considered the possible effects of three measures of weight: the reported weight gain from age 25 to intake, body mass index (kg/m2), and an estimate of the percent body fat.2' The risk factors were measured at the intake examination with the exception of reported weight at age 25 and percent body fat which were determined at the second and third annual re-examinations, respectively.
Clinical CHD occurred during follow-up in 257 subjects, including 51 who developed angina pectoris without apparent infarction, 135 who suffered symptomatic myocardial infarction and fatal CHD events and 71 who suffered "silent" and clinically unrecognized infarction, as previously described in detail.18 20 The diagnosis of clinical CHD was made by an independent referee in this study. '7 Since the blood pressure measures were found to be significantly associated with the incidence of each of the three CHD categories, for purposes of simplification they are combined into the single category of manifest CHD. Among 3, 154 subjects at intake into the study, 2,648 completed the 8.5 years of follow-up, 2,831 completed at least 6.5 years, 2,972 completed at least 4.5 years and 3,108 completed at least 2.5 years.
For all WCGS subjects 92.5% of the total possible personyears of follow-up were completed and thus little bias is expected due to differential follow-up for subjects depending on levels of the risk factors.'9 Men who were lost to followup prior to possible occurrence of CHD were considered to be non-CHD subjects as has been typically assumed in most studies using the present methods of analysis. 22 The subjects were white males except for a small number of Orientals.
The serum cholesterol, reported weight gain since age 25 and percent body fat measurements were missing for 12, 146 and 274 subjects, respectively. These subjects were included in the analysis by substituting age-decade specific grand means for missing values.
Traditional cross-tabulation methods could not be used to assess the independent predictive strength of both systolic and diastolic blood pressure, since the subjects could not be simultaneously divided, for example, into tertiles of both systolic and diastolic blood pressure levels. This method also does not permit adjustment for other important risk factors and, with these necessarily broad groupings, neither systolic nor diastolic blood pressure is fully controlled when studying its companion blood pressure measure because of the strong association between these two factors. Consequently, a more sensitive multivariate risk analysis using the multiple logistic risk model was applied.
In the multiple logistic model, CHD risk (R) is represented by the equation, R 1/(1 + e -(Bo + BX,.. + BkXk)) where B0, B, . . , Bk are k + 1 logistic coefficients estimated from data consisting of CHD status at a specified time and measured levels for k risk factors, X,, X2 . . ., Xk, for each subject. Alternatively, the logistic model can be expressed in the linearized form In (R/(I -R)) = B0 + B,X, .
. . + BkXk where the quantity In (R/(1 -R)) is called a logit of R and is the transformation from which this model derives its name. The coefficients in the multiple logistic risk model were estimated from WCGS data by the method of maximum likelihood. The estimated logistic coefficients divided by their estimated standard errors obtained from asymptotic maximum likelihood theory provided test statistics with approximately "standard" normal distributions for assessing the statistical significance of each es-timated coefficient. The measure used for comparison of the predictive strength of the various blood pressure measures is the standardized relative risk. This estimates the (approximate) relative risks corresponding to changes in the risk factor scores by amounts equal to their respective standard deviations. This provides a particularly useful comparative measure of the predictive strength of the blood pressure measures, since they all have approximately the same distribution shapes. 20 The standard deviations for the distributions of risk factor scores have not been given but they can be computed from information that is provided. The standard deviation equals the 1n (standardized relative risk) divided by the logistic coefficient. Further discussion of the interpretation of the results of multiple logistic risk analysis is described elsewhere in detail.' 9 20 Previous comparisons of estimated and observed numbers of CHD cases in ten risk decile groups showed adequacy of the multiple logistic model as an appropriate basis for studying the CHD predictability of the various risk factors. '9 20 Continuous numerical determinations included the systolic and diastolic blood pressures (mm Hg) and the derived mean arterial and the pulse pressure. Blood pressure was measured in the subject's left arm while he was seated, resting the arm on a desk. The measurements were obtained by the same technician in the same phase of the examination and diastolic pressure was recorded at the point of disappearance of sound. Also treated as continuous measures were serum cholesterol (mg/100 ml), age, height and weight (from which the body mass index was derived) and the percent body fat. Two categorical factors were coded for the present multivariate analyses: current cigarette smoking status (0 = nonsmoker, 1 = smokes under one pack/day, 2 = smokes one pack/day, 3 = smokes over one pack/day) and behavior pattern (0 = Type B, I = Type A).
Multiple risk analysis using the logistic model was employed separately for the subjects in two intake age decades. Since age was included in this logistic model, adjustment for the effect of age trends within the two age decades is provided by the analysis. Analyses in separate age groups were used so any difference in predictive strength of blood pressure measured at different ages could be detected. This method provides an alternative to the use of age-blood pressure interaction terms'5 which are difficult to interpret. Table 1 describes the basic characteristics of the population under study. The relationship of the studied variables to the incidence of CHD has already been described. 18 In the first analysis using the multiple logistic risk model, the systolic and diastolic blood pressures were studied separately as predictors of CHD incidence, without adjustment for other important CHD risk factors. The logistic coefficients for systolic and diastolic blood pressures each showed strong relationship with the CHD incidence. For systolic pressure in the younger and older age decades, respectively, these were .0252 and .0239 and, for diastolic pressure, were .0252 and .0386. These results correspond to standardized relative risks in the two age decades of 1.43 (P < 0.00001) and 1.49 (P = 0.00002) for systolic pressure and 1.27 (P = 0.0022) and 1.47 (P = 0.00007) for diastolic pressure. Table 2 presents the results of logistic risk analyses which assessed the strengths of four blood pressure measures taken one at a time for predicting the CHD incidence, with adjustment for other major CHD risk factors. The measures included the systolic and diastolic pressures and two measures derived from them; the pulse pressure (i.e., systolic minus diastolic pressure) and the mean arterial pressure (i.e., diastolic plus one-third of pulse pressure). The logistic coefficients for the blood pressure measures were determined after adjustment for effects of age, serum cholesterol, cigarette smoking and behavior pattern on the CHD incidence. As can be seen, each of the four blood pressure measures was significantly associated with the CHD incidence in both age decades. As previously noted,'8 20 serum cholesterol, cigarette smoking and behavior pattern also were significantly associated with the CHD incidence in both age decades, but a significant association with CHD risk for age was only observed in the younger decade.
Results
Although weight was not found to be a significant predictor of the CHD risk in earlier multivariate analyses of either this population'7 20 or that of Framingham,22 an additional analysis using the multiple logistic model was done (not shown) to assess the predictive strengths of the systolic and diastolic blood pressures for the CHD risk, after adjustment for the four risk factors shown in table 1, and additionally for three measures of weight that included reported weight gain from age 25 years to intake, body mass index and percent body fat. In comparison with the data shown in table 2, 2 ) for the four other risk factors were noted. The three measures of weight showed essentially the same relationship to CHD incidence regardless of the blood pressure measure with which they were analyzed. The results that occurred when the weight measures were analyzed along with systolic blood pressure and the other risk factors in table 2 therefore provide a representative example of the general findings. For the body mass index, standardized relative risks of 1.06 (P = 0.57) and 1.29 (P = 0.047) were found in the younger and older decades, respectively. For the weight gain since age 25, the standardized relative risks were .89 (P = 0.18) and .87 (P = 0.22), respectively, in the two age groups. For the percent body fat, the standardized relative risks were 1.18 (P = 0.09) and .97 (P = 0.84), respectively, in the two age groups. Table 3 shows the coefficients of correlation observed between the different blood pressure measures and indicates expected close interrelationships. In particular, the close relationship between the systolic and diastolic blood pressure in each age group is shown in figure 1 along with the univariate distributions for each of these measures. Thus, although each of the four blood pressure measures was found to show strong relationship to the risk of CHD after adjustment for other risk factors, further joint analysis of the blood pressure measures is required to determine which measures have direct predictive strength. Table 4 shows the results of multivariate analysis using the multiple logistic risk model, in which six possible combinations of the blood pressure measures were studied in pairs to determine their adjusted predictive strengths for the risk of CHD in the two age decades. This analysis was also done with adjustment for age, total cholesterol, cigarette smoking and behavior pattern. Only minor changes were noted in the predictive strengths of these adjusting factors compared to the results shown in table 2. Therefore the detailed findings for these factors are not repeated in table 4. Interpretation of the results in table 4 are focused on the analysis which included both systolic and diastolic blood pressure, although findings obtained with other possible pairs of blood pressure measures are included for completeness. In the younger decade systolic btood pressure with a standardized relative risk of 1.29 (P = 0.03) is a substantially better predictor of CHD incidence than is the diastolic blood pressure with a standardized relative risk of .97 (P = 0.80). For men in the older decade, both systolic and The above analyses were done without any attempt to discriminate between subjects without and those with a known history of hypertension, in many of whom measured blood pressures might have been influenced by medications. However, it does not seem likely that different results would have been observed had this been considered since only a small fraction of known hypertensive subjects are adequately controlled by medication in general clinical practice.' Moreover, the systolic blood pressure has been found to be a better predictor of the CHD incidence than the diastolic pressure even in populations in which subjects with a history of hypertension were eliminated from those at risk.'" Nevertheless it was believed important to see if a crude estimate of treatment was reflected by any change in the relative predictive strengths of the systolic and diastolic pressure for the risk of CHD. This was done by comparing the systolic and diastolic pressures as predictors of CHD risk in those subjects with no reported history of hypertension and in whom the diastolic blood pressure was measured at intake below 95 mm Hg. This appeared preferable to attempting any study of the possible effects of antihypertensive medication in view of the poor reliability of obtaining valid histories of drug prescriptions as well as compliance in their usage. The results of this multivariate analysis using the multiple logistic risk model are shown in table 5 in which the comparative predictive strengths of the systolic and diastolic pressures for the CHD risk are shown after adjustment for the effects of the other risk factors. As can be seen, in both age groups the association of the antecedent blood pressures with the CHD incidence is essentially the same as that found when hypertensive subjects were included in the analysis (table 4) .
Discussion
An elevated blood pressure has been well demonstrated to be both a strong and an independent predictor for all major forms of cardiovascular disease,2 including coronary heart disease.'-"' Actuarial data from life insurance statistics indicate that even blood pressure levels generally considered to be in the upper ranges of normal carry a significant extra mortality in middle and older aged individuals.24 The relationship between arterial pressure and cardiovascular .0026 *The approximate relative risk (odds ratio) for a change in the risk factor by an amount equal to its standard deviation.
diseases appears to be a quantitative one2' 10 and, from this standpoint, there is little evidence of a numerical dividing line separating innocuous normotensive from adverse hypertensive blood pressure levels.2' 24 The risk of increased cardiovascular diseases appears to be related even to a single casual blood pressure determination, despite the effects of lability, diurnal variations, artifacts of measurement and the response to therapy. 2 20 In the present study the subjects were divided into two intake age decades, 39-49 and 50-59 years. In the younger decade, when analyzed separately the systolic blood pressure was found to be a stronger predictor of the CHD risk than the mean arterial, pulse or diastolic pressure, although the differences in predictive strengths were not large. In the older decade, when analyzed separately the systolic, diastolic and mean arterial pressures showed essentially the same predictive strength, while the pulse pressure showed somewhat less relationship to CHD. In general, these findings parallel those observed in a similar type of analysis from Framingham.'0 The present data did not confirm their finding'0 of a declining importance of the diastolic and a corresponding increase in importance of systolic blood pressure with advancing age. However, in both studies it was clearly found that the CHD risk is very significantly and independently related to the antecedent blood pressures and that this risk is proportional to the blood pressure level. When both systolic and diastolic blood pressures were analyzed jointly, the results suggest that systolic blood pressure has all of the predictive strength in the younger group.
Caution is required in any attempt at using these findings for the causal interpretation of the pathogenetic consequences of elevated blood pressure levels. There is a weakness in the level of statistical significance since attempts to sort out the predictive content of two highly correlated factors are inherently inefficient because of the correlation between the factors. This effect can be seen by comparing the results in tables 2 and 4. When systolic blood pressure is analyzed separately in table 2, the estimated standardized relative risk is 1.26 (P = 0.0026) in the younger age group. When it is analyzed jointly with diastolic blood pressure in table 4, the estimated standardized risk of 1.29 (P = 0.032) is essentially unchanged but is less statistically significant as indicated by the higher P value. The issue of chance variation is further complicated when we test the statistical significance of the difference between the standardized relative risks for systolic and diastolic blood pressure. This comparison is appropriate when we are trying to determine which of the two is more predictive. For the younger men this difference, 1.29 vs .97, has a significance probability (P = 0.215) which is suggestive but not conclusive. Nevertheless, in the younger age group the results suggest that the predictive strength found with diastolic pressure, analyzed separately, occurs because of its strong association with systolic blood pressure.
For the older age group systolic blood pressure with standardized relative risk of 1.30 (P = 0.11) is substantially, but not in a statistical sense, more predictive than diastolic blood pressure with a standardized relative risk of 1.18 (P = 0.32). With analysis in this joint context chance cannot be emphatically excluded as an explanation for the estimated predictive strength of these factors. Also the significance probability for the difference between these standardized relative risks is P = 0.76 so that caution is required in further interpretation of these results for men in the older decade.
The indications that the direct predictive strength for the CHD incidence in the younger subjects is carried by the systolic rather than the diastolic blood pressure is not surprising in view of the fact that the incidence of CHD in most prospective studies2' 10-14, 22 and mortality from cardiovascular diseases in insurance statistics7 28 have shown a stronger association with systolic than with diastolic blood pressure. These and other studies27 have shown that the CHD incidence is in fact poorly related to the degree of diastolic hypertension and that even modest elevations of systolic blood pressure have a considerable adverse significance of their own in a relationship that does not wane with age.2, 14, 26 The findings also are in harmony with the fact that although the severity of coronary atherosclerosis is associated with the duration28 and degree of elevated blood pressure, 8230 the association is stronger with systolic than with diastolic pressure.28 30 Association of the severity of coronary atherosclerosis has been found with isolated elevation of systolic pressure2' and prevails down to levels generally considered below the normal range,9 supporting the hypothesis of Pickering32 that isolated systolic hypertension predisposes to the incidence of myocardial infarction.
In spite of this impressive evidence, it has long been held32 and generally taught34-36 that the cardiovascular consequences of hypertension primarily derive from the diastolic component. Gubner26 pointed out that it is a misconception to regard an elevated systolic pressure as merely an accompaniment of diastolic hypertension and as being either in-nocuous33 or of no clinical importance.37 Although antihypertensive therapy is -almost always directed at the diastolic pressure, it has been emphasized that true prophylaxis may require a different approach.2-, 10 Perhaps this is particularly true of the adverse effects of hypertension on the CHD incidence, since this is the least complication of hypertension that is affected by reduction of blood pressure by drug therapy26 and, indeed, antihypertensive treatment has shown surprising little effect on either the incidence23 or prognosis38' 39 of coronary disease.
The concept of the innocuous nature of the systolic blood pressure probably stems both from fact and fallacy. Among the facts are that systolic pressure is extremely labile and isolated elevations of systolic pressure are widely prevalent in older age groups and difficult to lower by existing antihypertensive medications. Since it appears likely that systolic hypertension has pathologic significance of its own, it has been pointed out that it is as much a fallacy to regard its high prevalence in older age groups as innocuous as it would be to consider as benign the similar wide prevalence of high levels of average weight or of serum cholesterol.26
Wiggers"0 related systolic pressure to elasticity of the great vessels and diastolic pressure to peripheral resistance. Since the major abnormality in essential hypertension is an increased total peripheral resistance,41 the misconception arose42 that this is responsible for elevated diastolic blood pressure while systolic pressure is determined only by stroke volume and inelasticity of the large arteries. 43 The latter belief is reinforced by the realization that isolated systolic hypertension occurs in the presence of diminished aortic capacity as in coarctation of the aorta, increased left ventricular stroke output as in patients with complete heart blocks, A-V fistulas, and thyrotoxic states, and in the presence of increased rigidity of the aorta due to degenerative changes in the wall.25 Finally there is the general acceptance that hypertensive disease is determined by increased peripheral resistance that is reflected by an elevation of diastolic blood pressure, while the systolic pressure has little meaning,26 since it is secondary either to an elevated diastolic pressure or merely a concomitant of age-related loss of elasticity of the aorta and large arteries. 2 The evidence that prospective studies in the elderly have demonstrated a stronger predictor role for systolic than for diastolic pressure with regard to the incidence of both CHD and strokes continues to be largely ignored. 44 Koch-Weser42 also discussed the misconception of considering the systolic pressure as merely a secondary phenomenon in hypertension, pointing out that any rise in total peripheral resistance increases systolic, diastolic and mean pressures by the same amount, while an increase of cardiac output causes a greater increase of systolic than diastolic pressure. Regardless of whether mean arterial pressure is increased by raising cardiac output or total peripheral resistance, the systolic will rise more than the diastolic pressure and almost all hypertensive patients show this pattern. Thus, in the great majority of hypertensive patients the increase of systolic pressure exceeds that of diastolic pressure. He emphasized that the consideration of systolic pressure as primarily a reflection of degenerative change in large arteries is akin to the old belief that all hypertension is a consequence rather than a cause of arterial disease. Consideration of these findings indicates that it is no longer tenable to believe that systolic hypertension is innocuous and worthy of benign therapeutic neglect, as Koch-Weser again recently emphasized. '5 The SUMMARY Prognostic stratification was carried out on 518 patients < 65 years of age who were discharged from the hospital following a definite or probable acute myocardial infarction and followed for four months. The total population was made up of 272 patients hospitalzed in 1973 and 246 patients hospitalized in 1974; one hundred and forty-two variables were collected on each patient. The clinical characteristics of the 1973 and 1974 populations were remarkably similar, and both groups had a four-month posthospital cardiac mortality rate of 4%. Two prognostic stratification schemes were developed on the 1973 population which identified low and high risk groups with meaningfully different four-month cardiac death rates. Both stratification schemes were tested on the 1974 population, and one of the two schemes was validated as identifying a THE MAJORITY OF DEATHS from coronary heart disease are sudden, develop outside the hospital, and frequently occur in patients with a prior history of coronary disease.'
In an attempt to reduce the mortality from coronary disease, various strategies have been tried including mobile coronary care units, satellite industrial coronary units, and community emergency rescue squads. These approaches require significantly increased cardiac mortality rate in the high as opposed to the low risk group. The four-month posthospital cardiac mortality rate was 3% in the low and 14% in the high risk group (Z = 2.70, P < 0.003). The high risk group was characterized by two or more of the following characteristics: 1) history of angina at ordinary levels of activity or at rest; 2) CCU hypotension and/or congestive heart failure; 3) ventricular premature beat frequency > 20/hr on a sixhour electrocardiographic tape recording. The low risk group had none or only one of the above characteristics. The prognostic power of this stratification scheme is such that sixteen percent of the posthospital population can be identified as high risk, and this subgroup contains forty-six percent of the patients who die of cardiac cause in the four-month posthospital interval. a very rapid response time, and even then the successes have been few relative to the enormity of the problem.5
In the late 1960s our group was involved in a study of the pre-hospital phase of myocardial infarction.5 The findings indicated that an immediately available industrial coronary unit did not reduce the mortality rate of on-work employees handled by this method when compared to off-work employees using the traditional community approach. It became apparent that a reduction in mortality would require the identification of patients with increased mortality risk so that appropriate prophylactic and preventive therapy could be administered. In 1974, we described a quantitative method for identifying patients who were at high risk of dying within two years after hospital discharge from myocardial infarction. 8 The unrestricted age of the population, the cumbersome statistical analysis, and the long two-year follow-up period impaired the clinical usefulness of applying
